<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mutations in the gene for fibrillin-1 (FBN1) cause <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>), an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">heritable disorder</z:e> of connective tissue with prominent manifestations in the skeletal, ocular, and cardiovascular system </plain></SENT>
<SENT sid="1" pm="."><plain>FBN1 mutations have also been identified in a series of related <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">disorders of connective tissue</z:e> collectively termed type-1 fibrillinopathies </plain></SENT>
<SENT sid="2" pm="."><plain>We have developed temperature-gradient gel electrophoresis (TGGE) assays for <z:hpo ids='HP_0000001'>all</z:hpo> 65 FBN1 exons, screened 126 individuals with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>, other type-1 fibrillinopathies, and other potentially related <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">disorders of connective tissue</z:e> for FBN1 mutations, and identified a total of 53 mutations, of which 33 are described here for the first time </plain></SENT>
<SENT sid="3" pm="."><plain>Several mutations were identified in individuals with fibrillinopathies other than classic <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e>, including <z:hpo ids='HP_0002617'>aneurysm</z:hpo> of the ascending aorta with only minor <z:hpo ids='HP_0000924'>skeletal anomalies</z:hpo>, and several individuals with only skeletal and ocular involvement </plain></SENT>
<SENT sid="4" pm="."><plain>The mutation detection rate in this study was 42% overall, but was only 12% in individuals not fulfilling the diagnostic criteria for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>, suggesting that clinical overdiagnosis is one reason for the low detection rate observed for FBN1 mutation analysis </plain></SENT>
</text></document>